Inspire Medical Systems, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position
Inspire Medical Systems, Inc. (INSP) had Debt Securities, Available-for-sale, Unrealized Loss Position of $192.26 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-03
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $192.26M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $143.93M.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $39.70M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $62.46M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $192.26M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $143.93M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $39.70M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $62.46M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $78.74M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $79.62M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $81.13M 10-K · filed 2026-02-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |